- Home
- ROIV vs LULU Comparison
ROIV vs LULU Comparison
Compare ROIV & LULU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | LULU |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 17.8B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ROIV | LULU |
|---|---|---|
| Price | $27.08 | $143.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 25 |
| Target Price | $28.94 | ★ $190.26 |
| AVG Volume (30 Days) | ★ 4.5M | 2.4M |
| Earning Date | 05-28-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 13.26 |
| Revenue | $29,053,000.00 | ★ $11,102,600,000.00 |
| Revenue This Year | N/A | $5.52 |
| Revenue Next Year | $744.61 | $4.68 |
| P/E Ratio | ★ N/A | $10.72 |
| Revenue Growth | N/A | ★ 4.86 |
| 52 Week Low | $10.58 | $142.10 |
| 52 Week High | $30.33 | $340.25 |
Technical Indicators
Market Signals| Indicator | ROIV | LULU |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 33.53 |
| Support Level | $26.94 | N/A |
| Resistance Level | $27.94 | $184.31 |
| Average True Range (ATR) | 0.85 | 5.52 |
| MACD | -0.12 | -1.14 |
| Stochastic Oscillator | 14.42 | 6.09 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About LULU lululemon athletica inc.
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 800 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 45 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.